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Bordetella pertussis is a re-emerging human respiratory pathogen whose infectious 
process is not fully understood, hampering the design of effective vaccines. The 
nature of bacterial attachment to host cells is a key event in the outcome of the 
infection. However, host cell receptors involved in B. pertussis colonization of the 
respiratory tract are still under investigation. Here, we report that cholesterol-rich 
domains are involved in B. pertussis adhesion to epithelial cells. Treatment of A549 
cells with cholesterol-sequestering drugs such as methyl-P-cyclodextrin, nystatin, 
or filipin resulted in a significant decrease ofB. pertussis attachment. Confocal laser 
microscopy studies showed B. pertussis associated with cholesterol-rich domains. 
Accordingly, B. pertussis was found in detergent-resistant membrane domain 
fractions isolated from bacterial-infected A549 cells. Our results indicate a main 
role of filamentous hemagglutinin, an environmentally regulated virulence factor, 
in this interaction, and a specific affinity for cholesterol, one of the major 
components of traqueal secretions, which might additionally contribute to the 
effective colonization of the respiratory tract.
Introduction
Bordetella pertussis is the etiologic agent of whooping cough, 
a re-emerging infectious disease. Upon entering the human 
host, the bacterium initiates the colonization of the respira­
tory tract by adhering to epithelial cells, which is a central 
phenomenon in the pathogenesis of B. pertussis. The inter­
action between virulent B. pertussis and the host involves 
several factors. Some of them are fairly well characterized, 
such as filamentous hemagglutinin (FHA), a major adhesin 
of this pathogen, and its docking molecules, namely lactosyl 
ceramides of ciliated respiratory cells (Prasad et al., 1993), 
sulfated sugars at the surface of epithelial cells (Hannah 
et al., 1994), and integrins in leukocytes (Reiman et al., 
1990). However, much of this interaction is still unknown.
In recent years, it has been recognized that a variety of 
pathogens interact with microdomains in the plasma mem­
brane known as lipid rafts, which eventually determines the 
outcome of the infection (Zaas et al., 2005). Rafts are 
membrane microdomains enriched in cholesterol and glyco­
sphingolipids. Lipid rafts are characterized by their insolu­
bility in cold Triton X-100 and have thus been termed 
detergent-resistant membrane domains (DRMs). Because 
of their high lipid content, these detergent-insoluble do­
mains float to a low density during gradient centrifugation 
(Brown & Rose, 1992). An important feature of lipid rafts is 
their highly dynamic nature, which allows the transient 
formation of membrane platforms that build up molecular 
machineries implicated in cell signaling (Shaul & Anderson, 
1998) and endocytosis (Nichols, 2003). Several bacteria have 
been found to co-opt the mechanism of lipid rafts-mediated 
endocytosis in order to adhere, invade, and remain viable 
inside host cells (Zaas et al., 2005). Likewise, we recently 
found plasma membrane cholesterol domains to play a 
crucial role in neutrophils (PMN) uptake of non-opsonized 
B. pertussis and bacterial intracellular survival (Lamberti 
etal., 2008). Here we investigated whether cholesterol is also 
involved in B. pertussis interaction with epithelial respiratory 
cells. The results indicate that lipid rafts, and cholesterol 
itself, play a significant role in bacterial interaction with 
epithelial cells and FHA is a key factor in this process.
Materials and methods
Bacterial strains and growth conditions
Bordetella pertussis strain B213, a streptomycin-resistant 
derivate of Tohama I, was transformed with plasmid 
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pCW505 (Weingart et al., 1999) (kindly supplied by Dr 
Weiss, Cincinnati, OH), which induces cytoplasmic expres­
sion of green fluorescent protein (GFP) without affecting 
growth or antigen expression (Weingart et al., 1999). In 
some experiments, BPGR4, a Tohama-derived mutant lack­
ing expression of FHA (Locht et al., 1992) transformed with 
plasmid pCW505, was used. Bacteria were stored at — 70 C 
and recovered by growth on Bordet Gengou agar (BGA) 
plates supplemented with 15% defibrinated sheep blood 
(bBGA) at 35 C for 3 days. Virulent bacteria were subse­
quently plated on bBGA, cultured for 20 h at 35 °C and used 
in adhesion assays.
In some experiments, Escherichia coli DH5a transformed 
with plasmid PML2, a pSMIO (Selbitschka et al., 1995) 
derivative, which induces cytoplasmic expression of GFP 
(a generous gift from Dr Lagares, Institute of Biochemistry 
and Molecular Biology, La Plata, Argentina), was used.
Cells and growth conditions
The human alveolar epithelial cell line A549 (human lung 
type II pneumocyte) (ATCC CCL185, Rockville, MD) was 
cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% of fetal bovine serum (FBS), 
lOOUml. 1 penicillin, and 100 mg ml. 1 streptomycin 
(Sigma, St. Louis, MO) at 37 °C in 5% CO2. Routine 
subcultures for A549 pneumocytes were performed at 1:3 
split ratios by incubation with 0.05% trypsin-0.02% EDTA 
for 5 min at 37 C. For the Bordetella adherence assay, 
epithelial cells were cultured to 80% confluence.
Antibodies
The following antibodies were used: mouse monoclonal 
antibodies (mAbs) against human caveolin-1 (Pharmingen, 
San Diego, CA), mouse mAb against the human transferrin 
receptor (Pharmingen), and polyclonal rabbit antibody 
against human flotillin-1 (Santa Cruz Biotechnology, Santa 
Cruz, CA).
Immunoglobulin G (IgG) fractions from pooled sera of 
pertussis patients with high titers against B. pertussis, as 
measured by enzyme-linked immunosorbent assay (Nagel 
etal., 1985), were isolated as described previously (Rodriguez 
et al., 2001). Polyclonal mouse anti-FHA B. pertussis antiser­
um was generated as described before (Sato & Sato, 1984).
Treatment of A549 cells with cholesterol- 
affecting drugs
Cholesterol sequestration was achieved by incubating A549 
cells with 10 mM of methyl-P-cyclodextrin (MPCD) (Sigma) 
(15 min at 37 °C), or 35 pg ml. 1 of nystatin (Sigma) 
(30 min at 37 °C), or 5 pg ml. 1 of filipin (Sigma) (30 min 
at 37 °C) in serum-free DMEM medium plus bovine serum 
albumin (BSA) (0.2%) and lovastatin (5 pg ml. ') (Sigma) 
(DMEM-BSA-L). Cells were then washed, suspended in 
DMEM-BSA-L, and used immediately. No decrease in cell 
viability was detected after treatment as determined by 
trypan blue exclusion. In selected experiments, cholesterol 
replenishment was performed by incubation of MPCD- 
treated A549 cells with 8 mg ml. 1 of water soluble choles­
terol (Sigma) in DMEM-BSA for 30 min at 37 °C or with 
FBS (20%) in DMEM-BSA for 3 h at 37 °C.
Total cellular cholesterol in treated and untreated 
A549 cells was determined using the Amplex Red cholesterol 
assay kit (Molecular Probes). Under the experimental 
conditions used, the 54 ± 2% of total cellular cholesterol 
was removed by MPCD treatment. The cellular choles­
terol content was found to be restored (98 ±1%) upon 
replenishment.
Binding assays
Attachment assays were performed as described in Rodri­
guez et al. (2006), with minor modifications. Briefly, cells 
were seeded on glass coverslips in 24-well tissue culture 
plates (Nunc, Rockside, Denmark) and incubated for 18 h. 
Monolayers were washed twice with sterile phosphate- 
buffered saline (PBS) and treated with or without cholester­
ol-affecting drugs as described above. Cells were then 
incubated with either GFP-expressing B. pertussis at a multi­
plicity of infection (MOI) of 150 bacteria per cell for 2h 
at 37 °C or 17 pg ml. 1 of purified native FHA (Glaxo­
SmithKline) in DMEM-BSA-L for 1 h at 37 °C. To facilitate 
bacterial interaction with epithelial cells, plates were centri­
fuged for 5 min at 640 g. No changes in the number of viable 
A549 cells were detected after incubation with either bacter­
ia or FHA. After incubation, the monolayers were washed 
with DMEM plus BSA (0.2%), before fixation with paraf­
ormaldehyde. The number of adherent bacteria per cell was 
estimated by fluorescence microscopy examination of 20 
randomly selected fields showing a minimum of seven 
epithelial cells per field. The association of FHA with A549 
cells was investigated both by fluorescence microscopy and 
by flow cytometry (Becton Dickinson, Lincoln Park, NJ). To 
this end, A549 cells treated with or without PBS-EDTA 
(0.2%) were incubated with anti-FHA mouse serum, fol­
lowed by incubation with an fluorescein isothiocyanate- 
conjugated F(ab')2 fragment of goat anti-mouse IgG (Jack- 
son ImmunoResearch, West Grove). All experiments were 
performed at least three times in duplicate.
In some experiments, GFP-expressing B. pertussis 
(6 x 106) were incubated with 1.8pgmL_1 of cholesterol 
(Sigma) in DMEM medium plus BSA (0.2%) for 1 h at 
37 C. After three washing steps, bacteria were incubated 
with A549 cells at a MOI of 150.
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In control experiments, attachment of GFP-expressing 
E. coli DH5a was evaluated as described above at a MOI 
of 500.
Cholesterol-binding studies
Bacterial cholesterol-binding capacity was investigated as 
described elsewhere (Rostand & Esko, 1993) with some 
modifications. Briefly, 1 pg of cholesterol diluted in ethanol 
was dried onto a microtiter plate at room temperature. 
Cholesterol-treated plates were then washed six times with 
PBS and blocked with 1% BSA in PBS for 1 h at 37 °C. 
Bacteria (wild type or BPGR4 strain) were added to the 
plates (2 x 107 bacteria per well) and incubated for 1 h at 
37 C. Non-adherent bacteria were removed by three wash­
ing steps with PBS. Human IgG anti-B. pertussis antibody 
was added to each well, and plates were incubated at 30 C 
for 2 h. After three washing steps, anti-human IgG-perox- 
idase conjugate antibodies were added to each well. The 
plates were then incubated at 37 C for 2h. After three 
washing steps, the enzyme reaction was initiated by the 
addition of O-phenylene diamine (0.1 mg ml. ') and H2O2 
(30 volumes in 100 mL citrate-phosphate buffer, pH 5). 
After 15 min in the dark at room temperature, the reaction 
was stopped by the addition of H2SO4 (4N). Bacteria 
attached to the wells were estimated by the A492nm. Wells 
coated with ethanol or blocking agent alone were used as 
control of nonspecific binding.
Cell fractionation and isolation of DRMs
DRMs of A549 cells incubated either with B. pertussis or 
FHA were isolated as follows: A549 cells (1 x 107 cells) 
grown at 80% confluence were incubated for 2h at 37 C 
with B. pertussis at a MOI of 150 bacteria per cell, or for 1 h 
at 37 °C with 17 pg ml. 1 of purified FHA. Triton-insoluble 
cell components were then isolated according to a previously 
published protocol (Chamberlain et al., 2001). In brief, cells 
were washed twice with cold PBS and scraped from the 
dishes into PBS. The cell pellet was suspended in ice-cold 
Tris-buffered saline (TBS) (20 mM Tris, pH 7.4, 1 mM 
EDTA, and 140 mM NaCl) containing 1% Triton X-100, 
1 mM phenylmethylsulfoxide, and 1% protease inhibitor 
cocktail (Sigma), and the cells were passaged 10 times 
through a 27G1/2 needle. The cell lysate was centrifuged at 
800 g for 10 min at 4 C, and the postnuclear supernatant 
was adjusted to 40% sucrose in TBS, placed at the bottom of 
an SW41 centrifuge tube (Beckman Instruments) and 
layered with 6 mL of 30% sucrose in TBS and 3 mL of 5% 
sucrose in TBS. After centrifugation at 247 000g for 15 h at 
4 C in a swinging bucket rotor (model SW41, Beckman 
Instruments), 1-mL fractions were collected from the top of 
the gradient (fraction 1) to the bottom (fraction 12). 
Proteins from each fraction were precipitated with 10% 
trichloroacetic acid in the presence of 0.02% sodium deox­
ycholate as a carrier. Samples were suspended in 50 pL of 
PBS and stored at — 20 °C until use.
In some experiments, cells were treated with 0.5% Triton 
X-100 plus 0.5% saponin (Sigma), a lipid raft-disrupting 
drug.
Analysis of sucrose density-gradient fractions
Sucrose density-gradient fractions of cells incubated with or 
without B. pertussis were analyzed for the presence of 
bacteria, caveolin, and transferrin receptor by dot-blot 
assays as follows: equal volumes (10 pL) of each fraction 
were spotted onto polyvinylidene fluoride (Immobilon 
PVDF, Millipore) and allowed to dry. Membranes were 
incubated for 2 h at room temperature in a blocking solu­
tion (PBS, 5% BSA), and then exposed for 2 h at room 
temperature to mouse monoclonal anti-caveolin-1 antibo­
dies, mouse monoclonal anti-transferrin receptor antibo­
dies, or human IgG anti-B. pertussis antibodies. After 
washing, specific binding of antibodies was visualized using 
alkaline phosphatase-conjugated goat anti-mouse IgG 
(Jackson ImmunoResearch, Baltimore Pike) or alkaline 
phosphatase-conjugated goat anti-human IgG (Jackson Im­
munoResearch, Baltimore Pike) as secondary antibodies, 
and nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl- 
phosphate (NBT/BCIP) (Bio-Rad) as a substrate.
Sucrose density-gradient fractions of cells incubated with 
or without FHA were analyzed by SDS-PAGE and immuno­
blotting. Fractions 1 and 2, 9 and 10, and 11 and 12 were 
pooled to allow immunoblot analysis of all gradient frac­
tions on a single polyacrylamide gel. Samples were sus­
pended in Laemmli sample buffer and run on 7% sodium 
dodecyl sulfate-polyacryilamide gel. Proteins were trans­
ferred to PVDF sheets (Towbin et al., 1979) and incubated 
with mouse polyclonal anti-FHA, mouse monoclonal anti- 
caveolin-1, or mouse monoclonal anti-transferrin receptor 
antibodies. Immunochemical detection was performed 
using alkaline phosphatase-conjugated goat anti-mouse 
IgG and NBT/BCIP (Bio-Rad) as a substrate.
Confocal microscopy
A549 cells were incubated with B. pertussis expressing GFP 
(MOI, 100) at 37 °C for 2h. Nonadherent bacteria were 
removed by washing with PBS. Cells were then fixed using 
paraformaldehyde. After fixation, A549 cells were washed 
twice with PBS, and incubated for 10 min at room tempera­
ture with PBS containing 50 mM NH4C1. After two washing 
steps, cells were permeabilized by incubation with PBS 
containing 0.1% saponin and 0.5% BSA for 30 min. Next, 
cells were incubated overnight at 4 C with anti-flotillin 
antibodies in the presence of 0.1% saponin and 0.5% 
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BSA. After three washing steps, cells were incubated with a 
CY-3-conjugated F(ab')2 fragment of goat anti-mouse IgG 
(Jackson ImmunoResearch, West Grove) for 30 min at 4 "C. 
To avoid cytophilic binding of antibodies, all incubations 
were performed in the presence of 25% heat-inactivated 
human serum. Microscopic analyses were performed using a 
confocal laser-scanning microscope (Olympus FV 300, 
Japan). The percentage of bacteria colocalizing with flotillin 
was calculated by analyzing at least 50 cells in randomly 
selected fields.
Statistical analysis
Student’s f-test (confidence level, 95%) or anova was used 
for statistical data evaluation. The significance of the differ­
ences between the mean values of the data evaluated by 
anova was determined using the least significant difference 
test at a confidence level of 95%. Results are shown as means 
and SD.
Results and discussion
Adhesion is a central phenomenon in the pathogenesis of 
B. pertussis. Adhesins and their counterparts in host cells play 
a substantial role in determining the outcome of a prokar­
yotic-eukaryotic interaction. Recent observations highlighted 
the role of cholesterol-rich domains in microbial pathogeni­
city. Lipid rafts are involved in the attachment, cell entry, and 
intracellular survival of several microorganisms such as 
Brucella suis (Naroeni & Porte, 2002), Chlamydia trachomatis 
(Jutras et al., 2003), and Mycobacterium bovis (Gatfield & 
Pieters, 2000). A recent report of our group showed that 
cholesterol-rich domains are involved in B. pertussis interac­
tion with human neutrophils and shape bacterial trafficking 
inside the immune cell, eventually leading to bacterial survi­
val (Lamberti et al., 2008).
The ability of B. pertussis to adhere to the respiratory 
epithelium is pivotal in the subsequent development of 
infection. Here we investigated whether plasma membrane 
cholesterol is involved in this process. To this end, we used 
A549 cells, a human alveolar cell line previously used to 
study B. pertussis interaction with human respiratory epithe­
lial cells (Ishibashi et al., 2001; Perez Vidakovics et al., 2006; 
Rodriguez et al., 2006). Cholesterol was depleted from cell 
plasma membrane by incubation with MPCD. Because 
MPCD does not interfere with cholesterol synthesis, the 
experiments described here were conducted in the presence 
of lovastatin, a drug that inhibits de novo cholesterol 
synthesis. As can be seen in Fig. 1, cholesterol depletion 
resulted in a significant decrease of virulent B. pertussis 
attachment (55%). The role of cholesterol in this process 
was further confirmed by incubation of A549 cells with 
cholesterol-binding drugs such as nystatin or filipin. Cells 
treated with any of the latter drugs showed a significant
Fig. 1. Bordetella pertussis attachment to A549 cells is dependent on 
cholesterol. A549 cells treated without (control) or with 10mM of 
MpCD, 5 pg ml_ 1 of filipin, or 35 mg mL 1 of nystatin were incubated 
with GFP-expressing B. pertussis (MOI, 150) for 2 h at 37 ,:C. In selected 
experiments, A549 cells treated with M|3CD were further incubated with 
8 mg mL 1 of water-soluble cholesterol in DMEM-BSA (MpCD + choles- 
terol) before incubation with B. pertussis. Bacterial attachment was 
evaluated by fluorescence microscopy. The data represent the 
mean ± SD of four independent experiments. The number of B. pertussis 
attached to A549 cells treated with MpCD, nystatin, or filipin differed 
significantly from the number of B. pertussis attached to either untreated 
cells or cells treated with MpCD and further incubated with water­
soluble cholesterol (*P < 0.05).
decrease in bacterial binding (Fig. 1). In control experi­
ments, we studied the effect of MPCD treatment of epithe­
lial cells on the attachment of E. coli DH5a, previously 
demonstrated to be independent of plasma membrane 
cholesterol (Pucadyil et al., 2004). As expected, the treat­
ment of cells with MPCD did not affect the binding capacity 
of E. coli (2.5 ± 0.9 and 2.3 ± 0.7 E. coli per cell in untreated 
and MpCD-treated A549 cells, respectively). In order to 
determine whether the decrease in B. pertussis attachment 
was specifically due to cholesterol removal, we next replen­
ished the cholesterol content of MpCD-treated cells by 
incubation with either cholesterol water-soluble or FBS. 
The increase in the cellular cholesterol content led to a 
concomitant increase in the ability of the bacteria to attach 
to the cell surface (Fig. 1), underlining the specific require­
ment of cholesterol in the infection process.
Cholesterol is a major sterol of mammalian cells. More 
than 90% of cellular cholesterol is located at the plasma 
membrane. Cholesterol is not uniformly distributed in the 
membrane, but is preferentially confined to lipid rafts, 
membrane microdomains enriched in cholesterol, glycoli­
pids, and glycosylphosphatidylinositol-anchored molecules. 
Lipid rafts form insoluble complexes (DRMs) upon mem­
brane solubilization with cold Triton X-100 (Rietveld & 
Simons, 1998). We next investigated whether B. pertussis 
interacts with lipid rafts by subcellular fractionation of 
A549-infected cells on a sucrose gradient. DRMs are typi­
cally isolated in low-density fractions. Figure 2a shows that
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Fig. 2. Lipid rafts are implicated in Bordetella pertussis interaction with host cells, (a) A549 cells were incubated with B. pertussis for 2 h at 37 ;C before 
subcellular fractionation. Equal volumes of each fraction were analyzed by a dot-blot analysis. Fractions were probed with IgG antibodies against 
8. pertussis, antibodies against the transferrin receptor and antibodies against caveolin. Representative results of one out of three independent 
experiments are shown, (b) A549 cells treated with (panel B) or without (panels A and C) MpCD were incubated for 2 h at 37 ,:'C with GFP-expressing 
8. pertussis (panels A and B) or GFP-expressing Escherichia coli DH5a (panel C). After washing, A549 cells were fixed and permeabilized 
before incubation with mouse antibodies against flotillin-1, followed by CY-3-conjugated F(ab'>2 fragment of goat anti-mouse IgG. Panels A and B 
show green fluorescent 8. pertussis colocalizing with red fluorescent-labeled flotillin, indicated by yellow areas (60% and 70% of colocalization, 
respectively). Panel C shows the lack of colocalization of green fluorescent E. coli DH5a with red fluorescent flotillin. The percentages of 
bacteria colocalizating with flotillin were calculated as described in Materials and methods. Representative panels of one out of three independent 
experiments are shown.
in our experimental setup DRMs were isolated in fractions 3 
and 4, in which caveolin, a lipid raft marker, but not 
transferrin receptor, a cell surface protein typically not 
associated with lipid rafts, was detected. Bordetella pertussis 
was found in fractions 3 and 4, suggesting its association 
with DRMs (Fig. 2a). Immunoreactivity of B. pertussis was 
also observed in fractions 8-12, possibly indicating that 
B. pertussis also binds to sites that are not located in lipid 
rafts. Nevertheless, the distribution of B. pertussis in the 
different fractions and its relative enrichment in DRMs are 
similar to those found in other pathogens that have been 
shown to target cholesterol-rich domains (Jutras et al., 
2003). We further investigated this association by confocal 
microscopy using another lipid raff marker, flotillin. 
Around 60% of B. pertussis were found to be colocalizing 
with flotillin-enriched areas, confirming the involvement of 
lipid rafts in B. pertussis interaction with epithelial cells (Fig. 
2b). Interestingly, Fig. 2b shows that, although less in 
amount, the characteristic lipid raff spots observed in 
control cells (panel A) are still present in MpCD-treated 
cells (panel B), suggesting that lipid rafts were not fully 
disrupted by this treatment. Remarkably, bacteria attached 
to cells treated with MPCD, although less in number, were 
mostly found to be colocalizing with flotillin-positive areas.
The significant reduction in B. pertussis adhesion after 
pretreatment of the cells with cholesterol-sequestering drugs 
led us to speculate that FHA, reported to be critical for 
B. pertussis adhesion to A549 cells (Rodríguez et al., 2006), 
could be involved in the interaction of this pathogen with 
cholesterol. A549 cells were incubated with purified FHA 
before Triton-insoluble cell components’ separation by 
a sucrose density gradient. Most of the cell-associated FHA 
was found in low-density fractions, indicating its association 
with DRMs (Fig. 3a). Although from these results we cannot 
rule out that FHA also binds to other molecules or even 
cholesterol present in the plasma membrane outside DRMs, 
this figure shows that FHA preferentially targets lipid rafts in 
the plasma membrane. Importantly, when cell lysates were 
incubated with saponin, a lipid raft-disrupting drug (Cham­
berlain et al., 2001), FHA was no longer detected in low-
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Fig. 3. Interaction of FHA with lipid rafts. 
Purified FHA was incubated with A549 cells for 
1 h at room temperature before subcellular 
fractionation, (a) The gradient fractions were 
analyzed by immunoblotting using anti-FHA 
antibodies, anti-transferrin receptor antibodies 
and anti-caveolin-1 antibodies, (b) FHA-treated 
cells were lysed using 0.5% Triton X-100 plus 
0.5% saponin and analyzed by immune blotting 
as in (a). Representative results of one out of 
three independent experiments are shown.
Fig. 4. Cholesterol sequestration affects FHA binding to A549 cells. 
A549 cells treated with or without 10 mM of MpCD for 15 min at 37 CC 
were incubated with 17 pg mlA1 of FHA for 1 h at 37 ,;C. After washing, 
surface-bound FHA was detected by incubation with mouse anti-FHA 
antibodies, followed by incubation with a fluorescein isothiocyanate- 
conjugated F(ab')2 fragment of goat anti-mouse IgG, and further 
analyzed by flow cytometry. Cell-associated FHA was determined 
by the geometric mean of cell-associated green fluorescence. FHA 
associated with MpCD-treated cells was expressed as a percentage of 
the level of FHA bound to untreated cells (control) arbitrarily set as 
100%. The data represent the mean±SD of three independent ex­
periments. The level of FHA associated with A549 cells treated with 
MpCD differed significantly from the level of FHA associated with 
MpCD-treated cells (*P < 0.05).
density fractions, but at the bottom of the gradient (Fig. 3b). 
Control experiments showed that purified FHA analyzed 
directly on gradients is found solely in the bottom fractions 
of the gradient (data not shown). In parallel experiments, we 
studied whether FHA association with A549 cells was 
affected by MPCD treatment. In cells pretreated with 
MPCD, the total amount of cell-associated FHA was sig­
nificantly reduced compared with the amount of cell- 
associated FHA in untreated cells (Fig. 4). These results, 
confirmed by fluorescence microscopy (data not shown), 
suggest that cholesterol-rich domains may function as plat­
forms that cluster docking molecules for FHA contributing 
to effective bacterial binding. At least three binding domains 
have been identified in mature FHA (Locht et al., 1993), 
including a heparin-binding domain that mediates attach­
ment to nonciliated cells, an arginine-glycine aspartate 
motif that mediates adherence to integrins in leukocytes 
and a carbohydrate recognition domain that mediates 
binding to lactosylceramides. Ceramides have been pro­
posed to be involved in the reorganization of the membrane 
and/or membrane rafts (Holopainen et al., 1998; Kolesnick 
et al., 2000). We speculate that lipid rafts forming an 
operational attachment platform might ensure a threshold 
local concentration of lactosylceramides and glycolipids, 
such as asialo-GMl, that facilitates an efficient bacterial 
binding.
In order to gain a better insight into B. pertussis interac­
tion with cholesterol-rich domains, we next explored 
whether B. pertussis directly interacts with cholesterol. 
Treatment of B. pertussis with cholesterol before incubation 
with A549 cells significantly reduced bacterial attachment 
(Fig. 5a), indicating that cholesterol, besides stabilizing host 
rafts, may function as a receptor for these bacteria. The 
binding of the B. pertussis FHA-deficient mutant (BPGR4) 
to A549 cells was not affected by cholesterol pretreatment of 
the bacteria, suggesting that the presence of FHA on the 
bacteria surface is critical for B. pertussis interaction with 
this molecule. This result was further confirmed by assessing 
bacterial adhesion to microtiter plates coated with choles­
terol. As shown in Fig. 5b, the absence of FHA on the 
bacteria surface led to a drastic decrease in the cholesterol- 
binding activity of B. pertussis. Association with cholesterol 
may stabilize B. pertussis interaction with lipid rafts; how­
ever, we cannot exclude the possibility that cholesterol 
outside rafts also participates in B. pertussis attachment to 
epithelial cells. Furthermore, cholesterol is also a major 
component of tracheal secretions and its concentration 
increases under conditions of hypersecretion as during 
B. pertussis infection (Reid, 1986; Widdicombe, 1987). 
Therefore, apart from promoting bacterial attachment to 
epithelial cells, the cholesterol-binding capacity of B. pertus­
sis might ensure bacterial colonization via other mechan­
isms, given the abundant reservoir of cholesterol this 
pathogen will encounter at the site of infection.
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Fig. 5. Cholesterol binding of Bordetella pertussis, (a) Wild-type (wt) 
B. pertussis and a mutant strain deficient in the expression of FHA 
(BPGR4) were incubated with (white bars) or without (black bars) 
1.8 pg mb' of cholesterol in DMEM plus BSA for 1 h at 37 ,;C. After two 
washing steps to remove nonbound cholesterol, bacteria were incubated 
with A549 cells for 2 h at 37 “C (MOI, 150). Cells were washed 
and fixed. Bacterial attachment was evaluated by fluorescence micro­
scopy. The data represent the mean±SD of four independent 
experiments. The attachment level of wt B. pertussis preincubated 
with cholesterol was significantly different from the attachment level 
of B. pertussis in the absence of cholesterol (*P < 0.05). (b) Binding 
of wt B. pertussis and BPGR4 to cholesterol-coated plates. Non­
specific binding, measured in wells coated with ethanol or blocking 
agent alone, was subtracted. Absorbance due to the attachment 
of wt was set as 100% of the attachment level. Data represent the 
mean±SD of three independent experiments. The binding of wt 
B. pertussis was significantly different from the binding of BPGR4 
(*P< 0.05).
Acknowledgements
This study was partially supported the SECyT (PICT 14522).
M.E.R. is a member of the Scientific Career of CONICET.
Y.L. and J.A.H. are doctoral fellows of CONICET.
References
Brown DA & Rose JK (1992) Sorting of GPI-anchored proteins to 
glycolipid-enriched membrane subdomains during transport 
to the apical cell surface. Cell 68: 533-544.
Chamberlain LH, Burgoyne RD & Gould GW (2001) SNARE 
proteins are highly enriched in lipid rafts in PC 12 cells: 
implications for the spatial control of exocytosis. P Natl Acad 
Sei USA 98: 5619-5624.
Gatfield J & Pieters J (2000) Essential role for cholesterol in entry 
of Mycobacteria into macrophages. Science 288: 1647-1651.
Hannah JH, Menozzi FD, Renauld G, Locht C & Brennan MJ 
(1994) Sulfated glycoconjugate receptors for the Bordetella 
pertussis adhesin filamentous hemagglutinin (FHA) and 
mapping of the heparin-binding domain on FHA. Infect 
Immun 62: 5010-5019.
Holopainen JM, Subramanian M & Kinnunen PK (1998) 
Sphingomyelinase induces lipid microdomain formation in a 
fluid phosphatidylcholine/sphingomyelin membrane. 
Biochemistry 37: 17562-17570.
Ishibashi Y, Reiman DA & Nishikawa A (2001) Invasion of human 
respiratory epithelial cells by Bordetella pertussis: possible role 
for a filamentous hemagglutinin Arg-Gly-Asp sequence and 
a5ßl integrin. Microb Pathogenesis 30: 279-288.
Jutras I, Abrami L & Dautry-Varsat A (2003) Entry of the 
Lymphogranuloma Venereum strain of Chlamydia trachomatis 
into host cells involves cholesterol-rich membrane domains. 
Infect Immun 71: 260-266.
Kolesnick RN, Goni FM & Alonso A (2000) Compartmen­
talization of ceramide signaling: physical foundations and 
biological effects. I Cell Physiol 184: 285-300.
Lamberti Y, Perez Vidakovics ML, van der Pol LW & Rodríguez 
ME (2008) Cholesterol-rich domains are involved in Bordetella 
pertussis phagocytosis and intracellular survival in neutrophils. 
Microb Pathogenesis 44: 501-511.
Locht C, Geoffroy MC & Renauld G (1992) Common accessory 
genes for the Bordetella pertussis filamentous hemagglutinin 
and fimbriae share sequence similarities with the papC and 
papD gene families. EMBO J11: 3175-3183.
Locht C, Bertin P, Menozzi FD & Renauld G (1993) The 
filamentous haemagglutinin, a multifaceted adhesion 
produced by virulent Bordetella spp. Mol Microbiol 9: 653-660.
Nagel J, de Graaf S & Schijf-Evers D (1985) Improved 
serodiagnosis of whooping cough caused by Bordetella 
pertussis by determination of IgG anti-LPF antibody levels. Dev 
Biol Stand 61: 325-330.
Naroeni A & Porte F (2002) Role of cholesterol and the 
ganglioside GM1 in entry and short-term survival of Brucella 
suis in murine macrophages. Infect Immun 70: 1640-1644.
Nichols B (2003) Caveosomes and endocytosis of lipid rafts. J Cell 
Sei 116: 4707-4714.
Perez Vidakovics ML, Lamberti Y, van der Pol WL, Yantorno O & 
Rodríguez ME (2006) Adenylate cyclase influences 
filamentous haemagglutinin-mediated attachment of 
Bordetella pertussis to epithelial alveolar cells. FEMS Immunol 
Med Mic 48: 140-147.
Prasad SM, Yin Y, Rodzinski E, Tuomanen EI & Masure HR 
(1993) Identification of a carbohydrate recognition domain in 
filamentous hemagglutinin from Bordetella pertussis. Infect 
Immun 61: 2780-2785.
Pucadyil TJ, Tewary P, Madhubala R & Chattopadhyay A (2004) 
Cholesterol is required for Leishmania donovani infection: 
FEMS Immunol Med Microbiol II (2009) 1-8 ® 2009 Federation of European Microbiological Societies
Published by Blackwell Publishing Ltd. All rights reserved
8 Y. Lamberti étal.
implications in leishmaniasis. Mol Biochem Parasit 133: 
145-152.
Reid LM (1986) The pathology of obstructive and inflammatory 
airway diseases. Eur J Respir Dis 147 (suppl): 26-37.
Reiman D, Tuomanen E, Falkow S, Golenbock DT, Saukkonen K 
& Wright SD (1990) Recognition of a bacterial adhesion by an 
integrin: macrophage CR3 (alpha M beta 2, CDllb/CD18) 
binds filamentous hemagglutinin of Bordetella pertussis. Cell 
61: 1375-1382.
Rietveld A & Simons K (1998) The differential miscibility of 
lipids as the basis for the formation of functional membrane 
rafts. Biochim Biophys Acta 1376: 467-479.
Rodríguez ME, Hellwig SMM, Hozbor DF, Leusen J, van der Pol 
W-L & van de Winkel JGJ (2001) Fc receptor-mediated 
immunity against Bordetella pertussis. J Immunol 167: 
6545-6551.
Rodríguez ME, Hellwig SMM, Perez Vidakovics ML, Berbers 
GAM & van de Winkel JGJ (2006) Bordetella pertussis 
attachment to respiratory epithelial cells can be impaired by 
fimbriae-specific antibodies. FEMS Immunol Med Mie 46: 
39-47.
Rostand K & Esko J (1993) Cholesterol and cholesterol esters: 
host receptors for Pseudomonas aeruginosa adherence. J Biol 
Chem 268: 24053-24059.
Sato H & Sato Y (1984) Bordetella pertussis infection in mice: 
correlation of specific antibodies against two antigens, 
pertussis toxin, and filamentous hemagglutinin with mouse 
protectivity in an intracerebral or aerosol challenge system. 
Infect Immun 46: 415-421.
Selbitschka W, Dresing U, Hagen M, Niemann S & Piihler A 
(1995) A biological containment system for Rhizobium meliloti 
based on the use of recombination-deficient (recA-) strains. 
FEMS Microbiol Ecol 16: 223-232.
Shaul PW &Anderson RG (1998) Role of plasmalemmal caveolae 
in signal transduction. Am J Physiol 275: L843-L851.
Towbin H, Staehelin T & Gordon J (1979) Electrophoretic 
transfer of proteins from polyacrylamide gels to nitrocellulose 
sheets: procedure and some applications. P Natl Acad Sci USA 
76: 4350-4354.
Weingart CL, Broitman-Maduro G, Dean G, Newman S, Peppier 
M & Weiss AA (1999) Fluorescent labels influence 
phagocytosis of Bordetella pertussis by human neutrophils. 
Infect Immun 67: 4264-4267.
Widdicombe JG (1987) Role of lipids in airway function. Eur J 
Respir Dis 153 (suppl): 197-204.
Zaas DW, Duncan M, Rae Wright J & Abraham SN (2005) The 
role of lipid rafts in the pathogenesis of bacterial infections. 
Biochim Biophys Acta 1746: 305-313.
© 2009 Federation of European Microbiological Societies
Published by Blackwell Publishing Ltd. All rights reserved
FEMS Immunol Med Microbiol II (2009) 1-8
